Cargando…

Transcriptome Analysis in Vulvar Squamous Cell Cancer

SIMPLE SUMMARY: The number of women, especially younger women, diagnosed with vulvar cancer, has been rising mainly due to the infection with human papilloma virus (HPV) over the last years. In contrast to other tumor entities, limited information on the underlying genetic changes is available, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prieske, Katharina, Alawi, Malik, Jaeger, Anna, Wankner, Maximilian Christian, Eylmann, Kathrin, Reuter, Susanne, Lebok, Patrick, Burandt, Eike, Blessin, Niclas C., Schmalfeldt, Barbara, Oliveira-Ferrer, Leticia, Joosse, Simon A., Woelber, Linn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699756/ https://www.ncbi.nlm.nih.gov/pubmed/34944992 http://dx.doi.org/10.3390/cancers13246372

Ejemplares similares

Targeted Therapeutic Approaches in Vulvar Squamous Cell Cancer (VSCC): Case Series and Review of the Literature
por: Woelber, Linn, et al.
Publicado: (2021)

Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer
por: Prieske, Katharina, et al.
Publicado: (2017)

E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer
por: Trillsch, Fabian, et al.
Publicado: (2016)

Pelvic lymphadenectomy in vulvar cancer and its impact on prognosis and outcome
por: Jaeger, A., et al.
Publicado: (2021)

BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer
por: Elazezy, Maha, et al.
Publicado: (2021)

T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer
por: Burandt, Eike, et al.
Publicado: (2022)

VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients
por: Ding, Yi, et al.
Publicado: (2022)

VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients
por: Kuerti, Sascha, et al.
Publicado: (2017)

Impact of Introducing a PACU24 Concept on the Perioperative Outcome of Patients with Advanced Ovarian Cancer Treated with Cytoreductive Surgery
por: Reuter, Susanne, et al.
Publicado: (2023)

The impact of Enhanced Recovery after Surgery (ERAS) pathways with regard to perioperative outcome in patients with ovarian cancer
por: Reuter, Susanne, et al.
Publicado: (2021)

Pelvic Lymphadenectomy in Vulvar Cancer – Does it make sense?
por: Woelber, Linn, et al.
Publicado: (2020)

Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study
por: Woelber, Linn, et al.
Publicado: (2021)

Comparison of PapilloCheck and Linear Array to Detect and Differentiate Human Papillomaviruses in Cervical and Tonsillar Smears from Females with Cervical Intraepithelial Lesions
por: Grimm, Donata, et al.
Publicado: (2018)

Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer
por: Volk, Annabelle, et al.
Publicado: (2023)

Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients
por: Leffers, Markus, et al.
Publicado: (2022)

Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2018)

Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2020)

Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis
por: Kempska, Joanna, et al.
Publicado: (2023)

Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation
por: Hamester, Fabienne, et al.
Publicado: (2019)

Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer
por: Legler, Karen, et al.
Publicado: (2018)

High mitochondrial content is associated with breast cancer aggressiveness
por: Lebok, Patrick, et al.
Publicado: (2021)

Beyond Bevacizumab: An Outlook to New Anti-Angiogenics for the Treatment of Ovarian Cancer
por: Mahner, Sven, et al.
Publicado: (2015)

Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer
por: Hamester, Fabienne, et al.
Publicado: (2022)

6q deletion is frequent but unrelated to patient prognosis in breast cancer
por: Lebok, Patrick, et al.
Publicado: (2021)

FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors
por: Dum, David, et al.
Publicado: (2022)

Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study
por: Woelber, Linn, et al.
Publicado: (2022)

Propensity Scoring after Multiple Imputation in a Retrospective Study on Adjuvant Radiation Therapy in Lymph-Node Positive Vulvar Cancer
por: Eulenburg, Christine, et al.
Publicado: (2016)

High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer
por: Weidemann, Sören, et al.
Publicado: (2023)

Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence
por: Dum, David, et al.
Publicado: (2022)

DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness
por: Jansen, Kristina, et al.
Publicado: (2021)

Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors
por: Weidemann, Sören, et al.
Publicado: (2021)

Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany
por: Grimm, Donata, et al.
Publicado: (2020)

Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid
por: Lennartz, Maximilian, et al.
Publicado: (2023)

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients
por: Büscheck, Franziska, et al.
Publicado: (2020)

Prognostic role of proliferating CD8(+) cytotoxic Tcells in human cancers
por: Blessin, Niclas C., et al.
Publicado: (2021)

p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer
por: Lebok, Patrick, et al.
Publicado: (2016)

Adjuvant Therapy in Lymph Node–Positive Vulvar Cancer: The AGO-CaRE-1 Study
por: Mahner, Sven, et al.
Publicado: (2015)

PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples
por: Möller, Katharina, et al.
Publicado: (2023)

Vulvar intraepithelial neoplasia: Incidence and long‐term risk of vulvar squamous cell carcinoma
por: Thuijs, Nikki B., et al.
Publicado: (2020)

The Vulvar Immunohistochemical Panel (VIP) Project: Molecular Profiles of Vulvar Squamous Cell Carcinoma
por: Garganese, Giorgia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qkh23lqog28rpaamr4qkljsaoc